NCT07614126
- Conditions
- CTNNB1, L-DOPA
- Locations
-
- CHU de Montpellier Montpellier, Hérault, France
Clinical trial condition
Explore clinical trials studying CTNNB1. Study availability and eligibility vary by location and protocol.
NCT07614126